Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Azilsartan Medoxomil Monopotassium: Precision in Hypertensio
2026-04-16
Azilsartan medoxomil monopotassium (TAK 491) sets a new benchmark for essential hypertension and cardiovascular disease research, offering unmatched receptor affinity and sustained efficacy. This guide delivers applied workflows, troubleshooting insights, and data-driven protocols to maximize translational value using APExBIO's high-purity compound.
-
CLK2 Targeting Overcomes Platinum Resistance in Ovarian Canc
2026-04-15
This study identifies Cdc2-like kinase 2 (CLK2) upregulation as a key driver of platinum resistance in ovarian cancer and elucidates its mechanistic role in DNA damage repair via BRCA1 phosphorylation. The findings provide a rationale for targeting CLK2 as a strategy for overcoming chemoresistance and suggest practical avenues for alternative splicing modulation research.
-
Gastrin I (human): Mechanistic Precision for Translational G
2026-04-14
Explore how Gastrin I (human) enables rigorous, mechanism-driven gastrointestinal research and translational innovation—bridging advanced organoid technology, pharmacokinetic modeling, and clinical relevance. This article details molecular mechanisms, experimental best practices, and strategic guidance for integrating human Gastrin I peptide in cutting-edge workflows, all while benchmarking APExBIO’s product for reproducibility and translational impact.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui
2026-04-13
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) provides researchers with a sensitive, quantitative method for measuring SOD enzyme activity in biological fluids, supporting studies of oxidative stress and antioxidative capacity. This kit is optimal for research applications requiring colorimetric detection of SOD activity but is not intended for diagnostic or clinical use.
-
Pomalidomide (CC-4047): Workflow Optimization for Myeloma Re
2026-04-13
Pomalidomide (CC-4047) empowers hematological malignancy research with precision cytokine modulation and robust performance in complex cellular models. Discover actionable protocols, advanced assay strategies, and troubleshooting frameworks that drive reproducibility and insight in multiple myeloma studies.
-
iRhom2 Regulates Olfactory Receptor Adaptation in Sensory Ne
2026-04-12
This study reveals that iRhom2, previously underexplored in the nervous system, plays a key role in regulating olfactory receptor (OR) expression and adaptation in mouse olfactory sensory neurons (OSNs). The findings illuminate the mechanistic feedback between odorant stimulation and the iRhom2/ADAM17 pathway, with implications for sensory adaptation and GPCR-mediated signaling.
-
Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pract
2026-04-12
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) is designed to protect proteins from endogenous proteolytic degradation during extraction and sample preparation, especially in workflows sensitive to divalent cations such as phosphorylation analysis. It is not suitable for applications requiring metal chelation or where EDTA-based inhibition is specifically needed.
-
ML-7 Hydrochloride: Precision Myosin Light Chain Kinase Inhi
2026-04-11
ML-7 hydrochloride's potency as a selective myosin light chain kinase inhibitor has redefined experimental strategies in cardiovascular research, particularly for ischemia/reperfusion injury and vascular endothelial dysfunction models. This guide delivers protocol-driven insights, troubleshooting tips, and translational context to maximize the value of ML-7 hydrochloride from APExBIO.
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Precision fo
2026-04-11
The HyperScribe T7 High Yield Cy3 RNA Labeling Kit empowers researchers with reproducible, high-yield synthesis of Cy3-labeled RNA probes, streamlining advanced applications like fluorescence in situ hybridization (FISH) and Northern blotting. This article delivers a data-driven, workflow-oriented guide—bridging cutting-edge sepsis research with hands-on protocol optimization and real-world troubleshooting.
-
Misoprostol: Protocol Guidance for Gastric Mucosal Protectio
2026-04-10
Misoprostol is a synthetic prostaglandin E1 analog designed for the study of gastric mucosal protection and NSAID-induced gastric ulcer prevention in preclinical settings. It is best suited for controlled in vivo and in vitro assays on gastrointestinal cytoprotection, and should not be used for diagnostic or clinical applications due to its research-only designation.
-
TG003: Selective Clk Kinase Inhibitor for Alternative Spl...
2026-04-10
TG003 is a potent and selective Cdc2-like kinase (Clk) family inhibitor used in splice site selection and platinum-resistant cancer research. As a well-characterized tool compound, TG003 enables quantitative modulation of serine/arginine-rich protein phosphorylation and alternative splicing in both in vitro and in vivo models.
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Workflow...
2026-04-09
The JC-1 Mitochondrial Membrane Potential Assay Kit streamlines robust, ratiometric ΔΨm measurement for apoptosis and mitochondrial function analysis across cancer, neurodegeneration, and immunomodulation models. Featuring dual-fluorescence sensitivity, built-in CCCP controls, and versatile workflow compatibility, this APExBIO kit empowers researchers tackling the frontiers of mitochondrial health and cell fate.
-
Strategic Innovation in Mitochondrial Membrane Potential ...
2026-04-08
This thought-leadership article delivers a comprehensive exploration of mitochondrial membrane potential (ΔΨm) as a nexus for apoptosis, cancer immunomodulation, and translational research. Blending mechanistic depth, critical literature integration, and strategic guidance, we spotlight how the APExBIO JC-1 Mitochondrial Membrane Potential Assay Kit (SKU: K2002) elevates experimental rigor and clinical relevance. The discussion synthesizes state-of-the-art research, including dual-pathway targeting for antitumor immunity, and offers actionable recommendations for translational researchers poised to drive next-generation breakthroughs in cancer, neurodegenerative diseases, and metabolic disorders.
-
Optimizing mRNA Translation: Practical Insights on Anti R...
2026-04-08
This article addresses common laboratory challenges in mRNA synthesis and cell viability assays, highlighting how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G (SKU B8175) boosts capping efficiency and translational output. Drawing on peer-reviewed data and real-world scenarios, we demonstrate the reagent’s value for translational research and protocol reproducibility.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit: Mechanis...
2026-04-07
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit enables robust, high-yield fluorescent RNA probe synthesis via in vitro transcription. Leveraging Cy3-UTP incorporation and T7 RNA polymerase, the kit achieves balanced labeling efficiency for applications such as in situ hybridization and Northern blotting. This article provides mechanistic, evidence-based insights supported by recent literature and benchmarking data.